Loss of BAP1 Defines a Unique Subtype of TP53-mutated De Novo AML and Confers Sensitivity to BCL-xL Inhibitors.
Blood（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined